Quarterly report pursuant to Section 13 or 15(d)

Business Combinations - Additional Information (Detail)

v3.22.2.2
Business Combinations - Additional Information (Detail) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Aug. 11, 2022
Jun. 10, 2022
Mar. 01, 2022
Sep. 14, 2021
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Minimum [Member]              
Business Acquisition [Line Items]              
Contingent earnout         $ 10,825,000    
VSL Acquisition [Member]              
Business Acquisition [Line Items]              
Total consideration $ 1,952,000            
Cash payment 1,700,000            
Deferred consideration 252,000            
VSL Acquisition [Member] | Developed Technology [Member]              
Business Acquisition [Line Items]              
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets $ 1,500,000            
Estimated useful lives 3 years            
VSL Acquisition [Member] | General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Acquisition related expenses $ 272,000            
VocaliD [Member]              
Business Acquisition [Line Items]              
Total consideration   $ 3,384,000          
Cash payment   1,609,000          
Deferred consideration   1,785,000          
Net working capital adjustment   (10,000)          
Tax deductible goodwill, acquisition   0          
Deferred tax liability   663,000          
VocaliD [Member] | Developed Technology [Member]              
Business Acquisition [Line Items]              
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets   $ 2,700,000          
Estimated useful lives   3 years          
VocaliD [Member] | General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Acquisition related expenses   $ 200,000          
March 2022 Acquisition [Member]              
Business Acquisition [Line Items]              
Total consideration     $ 5,881,000        
Cash payment     1,500,000        
Deferred consideration     2,707,000        
Net working capital adjustment     37,000        
Tax deductible goodwill, acquisition     2,842,000        
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets     2,700,000        
Equity consideration at closing     1,929,000        
Settlement of pre-existing receivable     976,000        
Acquired cash     684,000        
Contingent earnout     3,015,000        
Transaction cost     $ 270,000        
March 2022 Acquisition [Member] | Maximum [Member]              
Business Acquisition [Line Items]              
Estimated useful lives     10 years        
March 2022 Acquisition [Member] | Minimum [Member]              
Business Acquisition [Line Items]              
Estimated useful lives     3 years        
March 2022 Acquisition [Member] | General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Acquisition related expenses     $ 270,000        
Pandologic Ltd [Member]              
Business Acquisition [Line Items]              
Net working capital adjustment       $ 5,818,000      
Contingent earnout       44,900,000      
Pandologic Ltd [Member] | Contingent Consideration              
Business Acquisition [Line Items]              
Contingent earnout       39,512,000      
Pandologic Ltd [Member] | General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Acquisition related expenses             $ 2,161,000
Pandologic Ltd [Member] | Recognized in Compensation Expense Within General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Contingent earnout       5,388,000      
Pandologic Ltd [Member]              
Business Acquisition [Line Items]              
Total consideration       135,563,000      
Cash payment       58,733,000      
Net working capital adjustment       5,818,000      
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets       92,000,000      
Equity consideration at closing       31,500,000      
Deferred tax liability       $ 12,686,000 0 $ 0  
Deferred tax assets         0 0  
Goodwill not deductible for tax purposes         33,111,000 33,111,000  
Deferred tax assets, valuation allowance         $ 0 $ 0  
Pandologic Ltd [Member] | Israeli [Member]              
Business Acquisition [Line Items]              
Tax rate       23.00%   12.00%  
Pandologic Ltd [Member] | Maximum [Member]              
Business Acquisition [Line Items]              
Estimated useful lives           7 years  
Pandologic Ltd [Member] | Minimum [Member]              
Business Acquisition [Line Items]              
Estimated useful lives           4 years  
Pandologic Ltd [Member] | Common Stock [Member]              
Business Acquisition [Line Items]              
Consideration equity interest issued number of shares           352,330  
Pandologic Ltd [Member] | Developed Technology [Member]              
Business Acquisition [Line Items]              
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets       $ 20,000,000      
Estimated useful lives       4 years      
Stock Purchase Agreement [Member] | VSL Acquisition [Member]              
Business Acquisition [Line Items]              
Business acquisition, effective date of acquisition Aug. 11, 2022            
Business acquisition, name of acquired entity VSL            
Total consideration $ 1,952,000            
Cash payment 1,700,000            
Deferred cash payment 300,000            
Deferred consideration $ 252,000            
Stock Purchase Agreement [Member] | VocaliD [Member]              
Business Acquisition [Line Items]              
Business acquisition, effective date of acquisition   Jun. 10, 2022          
Business acquisition, percentage of ownership interests acquired   100.00%          
Business acquisition, name of acquired entity   VocaliD          
Business acquisition, date of acquisition agreement   Jun. 10, 2022          
Total consideration   $ 3,384,000          
Cash payment   1,609,000          
Deferred cash payment   2,000,000          
Deferred consideration   1,785,000          
Net working capital adjustment   $ (10,000)          
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member]              
Business Acquisition [Line Items]              
Business acquisition, effective date of acquisition     Mar. 01, 2022        
Business acquisition, percentage of ownership interests acquired     100.00%        
Business acquisition, date of acquisition agreement     Mar. 01, 2022        
Total consideration     $ 5,881,000        
Cash payment     1,500,000        
Deferred cash payment     3,000,000        
Deferred consideration     2,707,000        
Net working capital adjustment     37,000        
Settlement of pre-existing receivable     (976,000)        
Acquired cash     684,000        
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Maximum [Member]              
Business Acquisition [Line Items]              
Contingent earnout consideration     4,500,000        
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Common Stock [Member]              
Business Acquisition [Line Items]              
Equity consideration at closing     $ 1,929,000        
Consideration equity interest issued number of shares     116,550        
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member]              
Business Acquisition [Line Items]              
Business acquisition, effective date of acquisition       Sep. 14, 2021      
Business acquisition, percentage of ownership interests acquired       100.00%      
Business acquisition, name of acquired entity       PandoLogic      
Business acquisition, date of acquisition agreement       Jul. 21, 2021      
Total consideration       $ 135,563,000      
Cash payment       58,733,000      
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Maximum [Member]              
Business Acquisition [Line Items]              
Contingent earnout consideration       65,000,000      
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Common Stock [Member]              
Business Acquisition [Line Items]              
Equity consideration at closing       $ 31,500,000      
Consideration equity interest issued number of shares       1,704,822